Association between common iron store markers and hemoglobin in children with chronic kidney disease

Meredith A Atkinson1, Christopher B Pierce, Jeffrey J Fadrowski

  • 1Department of Pediatrics, Johns Hopkins University School of Medicine, Baltimore, MD, USA. matkins3@jhmi.edu

Insights

In children with chronic kidney disease (CKD), high serum ferritin levels are linked to lower hemoglobin (HGB). Low serum iron with normal/high ferritin may indicate iron-restricted erythropoiesis.

Area of Science:

  • Pediatric Nephrology
  • Hematology
  • Chronic Kidney Disease Research

Background:

  • Assessing iron status in pediatric chronic kidney disease (CKD) is crucial for managing hemoglobin (HGB) levels.
  • Current markers like serum ferritin and transferrin saturation (TSAT) have unclear sensitivity for predicting lower HGB in children with CKD.

Purpose of the Study:

  • To evaluate the association between iron status markers and HGB percentiles in children with mild-to-moderate CKD.
  • To identify key iron status indicators and clinical factors linked to lower HGB levels in this population.

Main Methods:

  • Analysis of iron status markers (ferritin, TSAT, serum iron) in 304 children from the CKiD Study.
  • Examination of HGB percentile values against KDOQI-defined thresholds for ferritin (≥100 ng/ml) and TSAT (≥20%).
  • Utilized regression tree analysis to pinpoint markers most associated with lower HGB percentiles.

Main Results:

  • Higher serum ferritin (≥100 ng/ml) was associated with lower HGB percentile values.
  • TSAT (≥20%) showed only a modest association with increased HGB percentile.
  • Lower glomerular filtration rate (GFR), serum iron <50 μg/dl, and ferritin ≥100 ng/ml were strongly linked to lower HGB percentile.

Conclusions:

  • GFR is significantly associated with HGB levels in pediatric CKD.
  • Elevated serum ferritin correlates with reduced HGB in this cohort.
  • Low serum iron, in the presence of normal/high ferritin and low HGB, may signal iron-restricted erythropoiesis.
Abstract

Related Concept Videos

Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...
Serum Studies: Renal Function Tests01:24

Serum Studies: Renal Function Tests

Renal function tests are crucial for assessing kidney health, monitoring disease progression, and evaluating the kidneys' efficiency in waste elimination, fluid balance, and electrolyte regulation. These tests offer critical insights into kidney function, even though routine measurements may appear normal until there is a significant decline in the glomerular filtration rate or GFR. Typically, signs of kidney impairment only become evident when the GFR falls to about 50% of its normal level.
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...